- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Conductus signs MRI pact with Siemens
Improving the image quality of low-field MRI is the focus of anagreement announced last week between Conductus and Siemens. Underthe terms of the deal, Conductus, a Sunnyvale, CA, developer ofhigh-temperature superconducting technology, will work with
Improving the image quality of low-field MRI is the focus of anagreement announced last week between Conductus and Siemens. Underthe terms of the deal, Conductus, a Sunnyvale, CA, developer ofhigh-temperature superconducting technology, will work with theGerman vendor to design superconducting receiver subsystems forSiemens' Open 0.2-tesla MRI scanner. The subsystems will includesuperconducting receiver coils, associated electronics and cryogeniccooling. Conductus is one of several firms using high-temperaturesuperconducting technology to boost the signal-to-noise ratioof low-field images (SCAN 11/8/95).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
